The limited genetic data we have reviewed in the current paper indicates a need for comparing genotypic information from differentiated, but now aggressive, thyroid cancers that (1) are and are not TSH-responsive and (2) are and are not T4-responsive in vitro. This evidence concerns the gene CD4 and thyroid gland carcinoma.